Aeolus– AEOl 10150 Significantly Improves Survival and Protects Lungs in Mice Exposed to Lethal Radiation
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
MISSION VIEJO, CA -- (Marketwired) -- 10/29/13 -- Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS)Optimal dose of AEOL 10150 improved survival by four times over untreated animalsTreatment with AEOL 10150 significantly reduced lung weights, a measure of inflammationAEOL 10150 treatment also improved respiratory function as measured by breathing frequency, a biotechnology…
Aeolus Provides Investor Update on Passage of Pandemic All-Hazards Preparedness Act of 2013
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
MISSION VIEJO, CA -- (Marketwire) -- 03/14/13 -- (OTCQB: AOLS)(OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel compounds to protect against radiological and chemical threats and for use in oncology, provided an update to investors on the Pandemic and All-Hazards Preparedness…